Myeloproliferative neoplasms: updates on molecular pathophysiology, diagnosis and treatment strategies.

Abstract excerpt

Myeloproliferative neoplasms (MPNs) are chronic hematopoietic stem cell disorders, including polycythemia vera, essential thrombocytosis, and primary myelofibrosis. The JAK2V617F mutation was identified in 2005, followed by the discovery of the JAK2 exon12, MPNW515 mutation, and CALR mutation. About 90% of patients with BCR/ABL negative MPNs have been shown to have one of these driver mutations. In addition,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Epigenesis, Genetic
• Share to BCR gene
• Share to CALR gene